Faes Farma, S.A. (BME:FAE)
Spain · Delayed Price · Currency is EUR 4.570
+0.025 (0.55%)
Aug 27, 2026, 5:35 PM CET
Faes Farma Market Cap
Faes Farma has a market cap or net worth of €1.42 billion as of August 27, 2026. Its market cap has increased by 8.54% in one year.
Market Cap
1.42B
Enterprise Value
1.73B
Revenue
711.06M
Ranking
n/a
PE Ratio
16.95
Stock Price
€4.57
ChartMarket Cap Chart
Since March 1, 1994, Faes Farma's market cap has increased from 163.59M to 1.42B, an increase of 765.29%. That is a compound annual growth rate of 6.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 1.42B | -11.86% |
| Dec 31, 2025 | 1.61B | 48.28% |
| Dec 31, 2024 | 1.08B | 9.15% |
| Dec 29, 2023 | 992.31M | -7.61% |
| Dec 30, 2022 | 1.07B | 5.44% |
| Dec 30, 2021 | 1.02B | 3.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.03B |
| Laboratorios Farmaceuticos Rovi | 3.06B |
| Almirall | 2.24B |
| Pharma Mar | 1.43B |
| Clínica Baviera | 942.75M |
| Oryzon Genomics | 232.45M |
| Prim, S.A. | 227.06M |
| Laboratorio Reig Jofre | 217.37M |